Hear from Francesca Holt, Clinical Research Technician, on what she enjoys most about working at #QuotientSciences. Interested in applying to join our team? Check out our openings today: bit.ly/3vXOjTl
April 11, 2025 at 8:46 PM
Hear from Francesca Holt, Clinical Research Technician, on what she enjoys most about working at #QuotientSciences. Interested in applying to join our team? Check out our openings today: bit.ly/3vXOjTl
Yesterday, our team attended the #CDMOLeadershipAwards in NYC. #QuotientSciences has been named a winner in the Small Molecule Dosage Form - Global category. This is a testament to our dedication to providing innovative, quality services while accelerating #drugdevelopment timelines. bit.ly/4kjcP5I
March 20, 2025 at 3:22 PM
Yesterday, our team attended the #CDMOLeadershipAwards in NYC. #QuotientSciences has been named a winner in the Small Molecule Dosage Form - Global category. This is a testament to our dedication to providing innovative, quality services while accelerating #drugdevelopment timelines. bit.ly/4kjcP5I
Will you be in Philadelphia for #CPHIAmericas next week? Meet with our team at booth #1220 to learn more about our expanded service offerings and how #QuotientSciences can help you overcome your program challenges. Request a meeting today: bit.ly/3G1GIbr
May 14, 2025 at 9:52 PM
Will you be in Philadelphia for #CPHIAmericas next week? Meet with our team at booth #1220 to learn more about our expanded service offerings and how #QuotientSciences can help you overcome your program challenges. Request a meeting today: bit.ly/3G1GIbr
At #QuotientSciences, our adaptive approach assures seamless, scalable solutions for your molecule’s development from preclinical through commercial #drugproduct formulation, manufacturing, and supply. Learn more about our unique, integrated offerings today: bit.ly/41WfU4A
Drug Product Development & Manufacturing
Pharma drug manufacturing services for small molecule and synthetic peptide drug products. Formulation development, clinical supply, and cGMP manufacturing drug product.
bit.ly
March 26, 2025 at 1:00 PM
At #QuotientSciences, our adaptive approach assures seamless, scalable solutions for your molecule’s development from preclinical through commercial #drugproduct formulation, manufacturing, and supply. Learn more about our unique, integrated offerings today: bit.ly/41WfU4A
#TranslationalPharmaceutics® has been a core part of #QuotientSciences’ approach for nearly two decades. Download our recently updated info sheet to learn more about how it works to accelerate drug programs: bit.ly/4iH9JqI
Translational Pharmaceutics® Integrated Drug Development Info Sheet
Quotient Sciences Translational Pharmaceutics® platform for drug development helps you achieve your goals by enabling a significantly faster transition through drug development by integrating on-deman...
bit.ly
April 11, 2025 at 8:48 PM
#TranslationalPharmaceutics® has been a core part of #QuotientSciences’ approach for nearly two decades. Download our recently updated info sheet to learn more about how it works to accelerate drug programs: bit.ly/4iH9JqI
Looking to achieve your molecule’s next milestone? At #QuotientSciences, our adaptive approach to #drugproduct development and manufacturing assures scalable solutions for molecule development—from preclinical through commercial formulation, manufacturing, and supply. Learn more: bit.ly/4iTsd85
Drug Product Development & Manufacturing Services Info Sheet
Achieve your molecule’s next milestone with fit-for-phase drug product formulationsBacked by trusted data and the expertise you need to navigate the increasing complexity of small molecule and synthet...
bit.ly
April 2, 2025 at 9:32 PM
Looking to achieve your molecule’s next milestone? At #QuotientSciences, our adaptive approach to #drugproduct development and manufacturing assures scalable solutions for molecule development—from preclinical through commercial formulation, manufacturing, and supply. Learn more: bit.ly/4iTsd85
In this #ColleagueStory feature hear from Henry Outram, Pharmaceutical Systems Administrator at our #Nottingham site. He discusses his career and what he enjoys most about being part of the #QuotientSciences team: bit.ly/4cujvv0 #MakeYourMarkAtQS
April 28, 2026 at 9:01 PM
In this #ColleagueStory feature hear from Henry Outram, Pharmaceutical Systems Administrator at our #Nottingham site. He discusses his career and what he enjoys most about being part of the #QuotientSciences team: bit.ly/4cujvv0 #MakeYourMarkAtQS
In this article with Drug Development & Delivery, John McDermott, VP of Scientific Consulting, shares how #QuotientSciences is leveraging advanced #AI and machine learning techniques to accelerate formulation development, achieving reductions in timelines of up to 50%. Learn more: bit.ly/3On9neT
February 13, 2026 at 3:10 PM
In this article with Drug Development & Delivery, John McDermott, VP of Scientific Consulting, shares how #QuotientSciences is leveraging advanced #AI and machine learning techniques to accelerate formulation development, achieving reductions in timelines of up to 50%. Learn more: bit.ly/3On9neT
With experience spanning 35 years and more than 1,300 Phase I studies delivered, learn how #QuotientSciences can help accelerate to first-in-human and proof of concept milestones with confidence: bit.ly/3KX2X4r
Early Clinical Development
Partner with us to design and deliver your early clinical programs.
bit.ly
October 21, 2025 at 1:57 PM
With experience spanning 35 years and more than 1,300 Phase I studies delivered, learn how #QuotientSciences can help accelerate to first-in-human and proof of concept milestones with confidence: bit.ly/3KX2X4r
Last week, we celebrated 35 years of #QuotientSciences. Our CEO, Thierry Van Nieuwenhove, reflects on our mission and success in combining science, agility, and culture to make a real difference for our customers, partners, and the lives of people around the world. Learn more: bit.ly/3SeKCQV
September 8, 2025 at 4:40 PM
Last week, we celebrated 35 years of #QuotientSciences. Our CEO, Thierry Van Nieuwenhove, reflects on our mission and success in combining science, agility, and culture to make a real difference for our customers, partners, and the lives of people around the world. Learn more: bit.ly/3SeKCQV
Latest news: #QuotientSciences has formed a scientific advisory board of established leaders from industry and academia. The board will contribute to driving innovation and technology aligned with company strategic priorities. bit.ly/3TOukPs
Quotient Sciences Announces Formation of Scientific Advisory Board
Advisory board will contribute to driving innovation and technology aligned with company strategic priorities. Inaugural board participants include established pharma & biotech executives, academics.
bit.ly
July 16, 2025 at 12:07 PM
Latest news: #QuotientSciences has formed a scientific advisory board of established leaders from industry and academia. The board will contribute to driving innovation and technology aligned with company strategic priorities. bit.ly/3TOukPs
#TranslationalPharmaceutics® has been a core part of #QuotientSciences’ approach for nearly two decades. Download our recently updated info sheet to learn more about how it works to accelerate drug programs: bit.ly/4iH9JqI
Translational Pharmaceutics® Integrated Drug Development Info Sheet
Quotient Sciences Translational Pharmaceutics® platform for drug development helps you achieve your goals by enabling a significantly faster transition through drug development by integrating on-deman...
bit.ly
May 28, 2025 at 11:59 AM
#TranslationalPharmaceutics® has been a core part of #QuotientSciences’ approach for nearly two decades. Download our recently updated info sheet to learn more about how it works to accelerate drug programs: bit.ly/4iH9JqI
Here's a look at how we celebrated #EmployeeAppreciationDay across our sites this month! At #QuotientSciences, we take pride in the dedication of our teams and recognize the impactful contributions they make each day! #lifeatquotient
March 28, 2025 at 3:03 PM
Here's a look at how we celebrated #EmployeeAppreciationDay across our sites this month! At #QuotientSciences, we take pride in the dedication of our teams and recognize the impactful contributions they make each day! #lifeatquotient
#TranslationalPharmaceutics® has been a core part of #QuotientSciences’ approach for nearly two decades. Download our recently updated info sheet to learn more about how it works to accelerate drug programs: bit.ly/4iH9JqI
Translational Pharmaceutics® Integrated Drug Development Info Sheet
Quotient Sciences Translational Pharmaceutics® platform for drug development helps you achieve your goals by enabling a significantly faster transition through drug development by integrating on-deman...
bit.ly
March 21, 2025 at 7:11 PM
#TranslationalPharmaceutics® has been a core part of #QuotientSciences’ approach for nearly two decades. Download our recently updated info sheet to learn more about how it works to accelerate drug programs: bit.ly/4iH9JqI
That's a wrap on a successful week at #DCAT in NYC! Our team enjoyed meeting and connecting with everyone at the event! If you weren't able to attend or missed us there, learn more about our innovative service offerings and extended capabilities today: bit.ly/3Mm5HpW #DCATWeek2025 #QuotientSciences
March 21, 2025 at 1:16 PM
That's a wrap on a successful week at #DCAT in NYC! Our team enjoyed meeting and connecting with everyone at the event! If you weren't able to attend or missed us there, learn more about our innovative service offerings and extended capabilities today: bit.ly/3Mm5HpW #DCATWeek2025 #QuotientSciences
Don't miss our upcoming #QuotientSciences Capability Expo at our state-of-the-art #Reading facility! This exclusive event will provide a unique opportunity to explore our facility, engage with industry experts, and enjoy captivating presentations on key topics. Reserve your spot now: bit.ly/3DAmHYm
March 19, 2025 at 9:33 PM
Don't miss our upcoming #QuotientSciences Capability Expo at our state-of-the-art #Reading facility! This exclusive event will provide a unique opportunity to explore our facility, engage with industry experts, and enjoy captivating presentations on key topics. Reserve your spot now: bit.ly/3DAmHYm
In our NEW ARTICLE, Matthew Paterson, CSO at #QuotientSciences, explains how integrated early development in #clinicaltrials offers a more robust development path with fewer handoffs >> bit.ly/4c7GkGc
#Biorasi2026 #CRO #biotech
#Biorasi2026 #CRO #biotech
First-In-Human Means More Than Safety: How Integrated Early Development Is Rewriting Proof-of-Concept
How can you move faster from First-in-Human to Proof-of-Concept? Learn how integrating real-time manufacturing and clinical data removes the gaps that stall early development programs.
bit.ly
February 24, 2026 at 1:53 PM
In our NEW ARTICLE, Matthew Paterson, CSO at #QuotientSciences, explains how integrated early development in #clinicaltrials offers a more robust development path with fewer handoffs >> bit.ly/4c7GkGc
#Biorasi2026 #CRO #biotech
#Biorasi2026 #CRO #biotech